2021
Redo‐transcatheter aortic valve replacement with the supra‐annular, self‐expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry
Attizzani GF, Dallan LAP, Forrest JK, Reardon MJ, Szeto WY, Liu F, Pelletier M. Redo‐transcatheter aortic valve replacement with the supra‐annular, self‐expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry. Catheterization And Cardiovascular Interventions 2021, 99: 869-876. PMID: 34533891, DOI: 10.1002/ccd.29941.Peer-Reviewed Original ResearchConceptsTranscatheter Valve Therapy RegistryTranscatheter aortic valveRedo-TAVRTVT RegistryRedo transcatheter aortic valve replacementBetter short-term outcomesTotal aortic regurgitationAortic valve replacementLow-risk patientsShort-term outcomesHospital mortalityIndex hospitalizationAortic regurgitationValve replacementDevice successEvolut RSafety profileMyocardial infarctionAortic valveEvolut PROPatientsRegistryMean gradientOutcomesEvolut
2018
Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999–2014
Goldsweig AM, Wang Y, Forrest JK, Cleman MW, Minges KE, Mangi AA, Aronow HD, Krumholz HM, Curtis JP. Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999–2014. Catheterization And Cardiovascular Interventions 2018, 92: 1104-1115. PMID: 29513365, DOI: 10.1002/ccd.27576.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionVentricular septal ruptureTimely primary PCIMortality ratePrimary PCIPercutaneous repairSeptal ruptureMyocardial infarctionRetrospective cohort studyUnadjusted mortality ratesUnrepaired patientsVSR repairFatal complicationCohort studyAnnual incidenceMedicare feeService beneficiariesPatientsIncidenceStudy periodMortalityHospitalizationInfarctionRepairPCI
2015
Comparison of Inhospital Mortality, Length of Hospitalization, Costs, and Vascular Complications of Percutaneous Coronary Interventions Guided by Ultrasound Versus Angiography
Singh V, Badheka AO, Arora S, Panaich SS, Patel NJ, Patel N, Pant S, Thakkar B, Chothani A, Deshmukh A, Manvar S, Lahewala S, Patel J, Patel S, Jhamnani S, Bhinder J, Patel P, Savani GT, Patel A, Mohamad T, Gidwani UK, Brown M, Forrest JK, Cleman M, Schreiber T, Grines C. Comparison of Inhospital Mortality, Length of Hospitalization, Costs, and Vascular Complications of Percutaneous Coronary Interventions Guided by Ultrasound Versus Angiography. The American Journal Of Cardiology 2015, 115: 1357-1366. PMID: 25824542, DOI: 10.1016/j.amjcard.2015.02.037.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overCoronary AngiographyCoronary Artery DiseaseCoronary VesselsCosts and Cost AnalysisFemaleFollow-Up StudiesHealth Care CostsHospital MortalityHumansLength of StayMaleMiddle AgedPercutaneous Coronary InterventionPostoperative ComplicationsRetrospective StudiesSurgery, Computer-AssistedUltrasonography, InterventionalUnited StatesYoung AdultConceptsPercutaneous coronary interventionCo-morbidity burdenInhospital mortalityAcute myocardial infarctionHospital stayCoronary interventionVascular complicationsMyocardial infarctionConventional angiography-guided PCIOutcomes of PCIAngiography-guided percutaneous coronary interventionDrug-eluting stent eraHierarchical mixed-effects logistic regression modelsHigher co-morbidity burdenUse of IVUSHigher hospital volumeLength of hospitalizationIntravascular ultrasound guidanceSubgroup of patientsNationwide Inpatient SampleCost of hospitalizationSignificant predictorsMixed effects logistic regression modelsMixed-effects linear regression modelsCost of care
2013
Adjunctive Pharmacology for Coronary Intervention
Faheem O, Forrest J. Adjunctive Pharmacology for Coronary Intervention. 2013, 143-156. DOI: 10.1007/978-1-4471-4528-8_11.Peer-Reviewed Original ResearchST-elevation myocardial infarctionStable coronary plaquesAcute coronary syndromeOral antiplatelet agentsElevation myocardial infarctionArterial thrombus formationAdjunctive pharmacologyRoutine PCIVon Willebrand factorCoronary syndromeCoronary interventionAntiplatelet agentsCoronary plaquesMyocardial infarctionThromboxane A2Plaque ruptureThrombus formationPlatelet activationClot formationPlatelet aggregationWillebrand factorPlateletsPivotal rolePlatelet adhesionInfarction